Gary D. Glick obtained his Ph.D. from Columbia University in 1988, studying organic chemistry under the direction of W. Clark Still. He then completed a National Institutes of Health postdoctoral fellowship at Harvard University where he studied bio-organic chemistry in the laboratory of Jeremy R. Knowles. In 1990, Dr. Glick joined the chemistry faculty at the University of Michigan in Ann Arbor, where he presently holds the Werner E. Bachmann chair in chemistry, is a professor in the Department of Biological Chemistry at the University of Michigan Medical School, and is a member of the training faculty for the interdepartmental Immunology and Medicinal Chemistry doctoral programs. He is also the founder and director of the Chemical Biology Doctoral Program at Michigan. Dr. Glick is also the founder of Lycera Corp, a leading biopharmaceutical company developing novel small molecule immunodulators for autoimmune disorders such as rheumatoid arthritis. In addition to building the company’s discovery team, Dr. Glick raised $39 M in equity financing for Lycera and currently serves as chief science officer.
Dr. Glick’s research interests are in drug discovery and development for autoimmune diseases and cancer; chemical-induced apoptosis; nucleic acid structure, folding and recognition; and molecular recognition of nucleic acids by proteins. He has served and continues to serve on numerous boards and committees, including the Bioorganic & Natural Products Chemistry Study Section of the National Institutes of Health and the Scientific Advisory Board of the National Arthritis Foundation, Michigan Chapter. He serves on several editorial boards, is Editor-in-Chief of Biopolymers, a leading journal publishing in the areas of biochemistry and biophysics, and was recently a counselor to the American Chemical Society Division of Biological Chemistry.
Dr. Glick’s scientific contributions have been recognized with a number of different awards including, an Arthritis Investigator Award from the National Arthritis Foundation, a Junior Faculty Research Award from the American Cancer Society, a Young Investigator Award from the National Science Foundation, a Camille Dreyfus Teacher-Scholar Award, a Research Fellowship from the Alfred P. Sloan Foundation, two Research Excellence Awards from the University of Michigan, and he is a Fellow of the American Association for the Advancement of Science.